{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019765","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2022-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.073339+00:00","generated_at":"2026-06-24T12:47:03.987885+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Celsion appoints Dr. Corinne Le Goff as President and CEO; Tardugno becomes Executive Chairman","bullets":["Dr. Le Goff, former CCO of Moderna, named CEO effective July 18, 2022.","New CEO base salary $624,000, signing bonus $50,000, target bonus 72% of base.","Inducement grants: option to buy 177,000 shares at $1.95; 53,000 restricted shares.","Michael Tardugno transitions to Executive Chairman with base salary of $500,000 (prorated to $240,000 in 2022).","Relocation allowance up to $75,000 for two years; severance of one year's salary upon termination without cause."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019765","json":"https://secwatch.observer/filing/0001493152-22-019765.json","markdown":"https://secwatch.observer/filing/0001493152-22-019765.md","text":"https://secwatch.observer/filing/0001493152-22-019765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/0001493152-22-019765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T12:47:03.987885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52dc02eea3","claim":"Michael H. Tardugno changed role as Executive Chairman at Imunon, Inc..","evidence_excerpt":"Michael H. Tardugno, the Company’s current Chairman, President and Chief Executive Officer, will transition from his current role to the position of Executive Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/0001493152-22-019765-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}